about
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part oneOverexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).Programmed death ligand-1 expression in non-small cell lung cancer.PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.High SOX2 levels predict better outcome in non-small cell lung carcinomas.Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.Opening of connexin 43 hemichannels is increased by lowering intracellular redox potential.Measurement of Domain-Specific HER2 (ERBB2) Expression May Classify Benefit From Trastuzumab in Breast Cancer.Objective measurement and clinical significance of TILs in non-small cell lung cancer.Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance.Possible involvement of different connexin43 domains in plasma membrane permeabilization induced by ischemia-reperfusion.Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research.Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung CancerCurrently used methods for identification and characterization of hemichannels.Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegenerationMarginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.Cell membrane permeabilization via connexin hemichannels in living and dying cells.Modulation of gap junction channels and hemichannels by growth factors.Regulation of intercellular calcium signaling through calcium interactions with connexin-based channels.Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.Strategies to design clinical studies to identify predictive biomarkers in cancer research.Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer.EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung AdenocarcinomaEffect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.Basic Overview of Current Immunotherapy Approaches in Cancer.Automated objective determination of percentage of malignant nuclei for mutation testing.In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.Connexin hemichannel composition determines the FGF-1-induced membrane permeability and free [Ca2+]i responses.Possible role of hemichannels in cancer.Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?Connexin 43 hemichannels mediate the Ca2+ influx induced by extracellular alkalinization.PD-L1 expression and tumor-infiltrating lymphocytes: Revisiting the antitumor immune response potential in breast cancer.Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images.Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer.Cation permeation through connexin 43 hemichannels is cooperative, competitive and saturable with parameters depending on the permeant species.Unvalidated antibodies and misleading results.
P50
Q28553703-F5D01F3B-0C47-4E27-9B7B-C2B4019E4936Q33557258-B4B26869-A68E-4CB3-90E3-BF007865258BQ34344857-D6EBB7B8-9030-43DD-B642-0793F85F29C0Q34384255-471F0B1A-6ECA-4040-9B46-B82C5A196820Q34454922-9DFCA0E6-51EB-4400-A255-86BE41FAFF12Q34688837-B57ACDDC-AA8F-4300-9905-09D26B6A293FQ35251561-4A7B86CE-196F-4307-8552-795909062908Q35850140-809C46F3-D555-477E-B464-2C6262B6A84AQ36009610-6FF422CC-20EE-4AF8-85CD-DD7370C88B08Q36047422-04B343A0-3D3D-45A1-9C93-D919DDE12DD5Q36280470-41723FE5-F97B-4D0C-BAB0-16AF86CA3F73Q36912901-24BDF23A-BA3C-4D6F-B2C1-CAABB6BF1929Q37083326-0BA6CE81-4421-44BD-917B-95A03312437CQ37087884-34EE2A4E-848C-4D2C-A671-E56F59960F2BQ37224643-03E23D5B-0252-43BE-900E-1DA98B4F29FFQ37226810-49B88C2A-E93D-494C-B3E5-6C302E3AA713Q37270004-F8D13EDF-8ECD-442F-BBF1-14873E9F8006Q37658459-6C60DC9E-99DB-49D9-9B0F-0FCBAEB6F1F2Q37769339-B23FEABA-238B-48A6-B6E2-75F73A32262AQ37973241-9371A4A3-953D-44F5-8078-F7D957686D2DQ37997699-8781F8B8-65AA-4719-B15C-B85541F49C27Q38750671-BCC69461-4C5A-428E-9A84-70A91596483AQ38770451-9A5640C2-0412-4E58-AB89-B90A1606F29CQ38796541-50C649F8-FE52-4275-AAC3-5BB700DC8432Q38807586-36859688-2E1A-43EC-96D3-01B24ED32148Q38845028-BE38F890-39ED-4BA7-8BF1-1340DE1E2704Q38850199-D9AA3BDD-F305-4BB7-B9EF-380F06096F1FQ38960732-FD1A4A1B-F86A-4876-9C65-475C79EF041DQ39013804-FD8BF94B-F407-4A7E-A167-AF72691DA9FDQ39578716-C8C7920D-14AA-44A0-8E6E-1BB1D054E5B1Q41068044-1B13A7D6-9DE9-4F8B-9794-25F0B503427EQ41362182-1754FAE1-D7EF-470A-80F1-25200457E27EQ41769744-B697057E-E211-4F60-B858-6F301D7C2B47Q42053149-A7CFFFEF-5F83-48BA-8468-4E5166D98D24Q42096460-4452A3EA-C22F-4731-BC76-76CEFD958347Q42393214-9A008C27-82EE-428E-A8D2-77C6E4F270E6Q42659721-E556E0E5-7FA1-4461-AD56-33C3704D90E8Q42690881-2460E2B0-F2D9-4FAB-BA68-4E4C7148842EQ42765233-28566A54-A960-4DE7-8E28-C3692CFA2F12Q42971341-B46F48BD-4C27-4D05-B8DC-C5E5D6BA39C2
P50
description
wetenschapper
@nl
name
Kurt A Schalper
@en
Kurt A Schalper
@nl
type
label
Kurt A Schalper
@en
Kurt A Schalper
@nl
prefLabel
Kurt A Schalper
@en
Kurt A Schalper
@nl
P31
P496
0000-0001-5692-4833